Skip to search formSkip to main contentSkip to account menu

apolipoprotein C-I

Known as: Apo C-I, Apolipoprotein C I, Apolipoprotein C1 
A 6.6-kDa protein component of VERY-LOW-DENSITY LIPOPROTEINS; INTERMEDIATE-DENSITY LIPOPROTEINS; and HIGH-DENSITY LIPOPROTEINS. Apo C-I displaces APO… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Aim: Identifying high-efficiency prognostic markers for colorectal cancer (CRC) is necessary for clinical practice. Increasing… 
Highly Cited
2013
Highly Cited
2013
ABSTRACT Hepatitis C virus (HCV) predominantly infects human hepatocytes, although extrahepatic virus reservoirs are being… 
Highly Cited
2008
Highly Cited
2008
ABSTRACT Accumulating evidence suggests that cellular lipoprotein components are involved in hepatitis C virus (HCV… 
Highly Cited
2008
Highly Cited
2008
Pancreatic cancer still remains one of the most lethal diseases and establishment of new therapy is needed. The purpose of this… 
Highly Cited
2005
Highly Cited
2005
The lack of a cell culture system to support hepatitis C virus (HCV) replication has hampered studies of this frequent cause of… 
2004
2004
Obese obob mice with strong overexpression of the human apolipoprotein C1 (APOC1) exhibit excessive free fatty acid (FFA) and… 
Highly Cited
2001
Highly Cited
2001
Apolipoprotein (APO) C1 is a 6.6-kDa protein present in plasma and associated with lipoproteins. Using hyperinsulinemic… 
1994
1994
To evaluate the role of apolipoprotein (apo) C-I in inhibiting lipoprotein binding to the low density lipoprotein receptor…